Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024

Code : CMI197

Pages :160

Formats :

Excel and PDF

Industry : Pharmaceutical

Regional Analysis

Viscosupplementation Market Regional Insights

To learn more about this report, request sample copy

North America has established itself as the dominant regional market for viscosupplementation and is expected to hold 47.8% of the market share in 2024. With a strong presence of leading medical device manufacturers and favorable reimbursement policies for knee osteoarthritis treatments, the U.S. accounts for the major share in the regional market. The growing adoption of minimally invasive procedures and rising obesity rates that increase the risk of osteoarthritis have further augmented demand over the years. Additionally, well-established distribution channels ensure easy accessibility to products across the region.

The viscosupplementation market in Asia Pacific has emerged as the fastest growing regional market globally. Countries like China, India, Japan, and South Korea are witnessing substantial rise in knee osteoarthritis cases driven by growing geriatric population and increasing lifestyle disease prevalence. This has boosted the uptake of viscosupplementation as an effective non-surgical treatment option. The market is also gaining from economic development across emerging nations, growing medical tourism, and improving access to healthcare facilities. Local manufacturers are augmenting their presence to cater to the rising needs. For instance, some Chinese companies have indigenously developed cost-effective viscosupplements to tap into the domestic demand.